[1]
Nikkhah, A. 2021. Role of Vesicular Monoamine Transporter2 (VMAT2) Inhibitors in Hyperkinetic Movement Disorders - A Brief Review. Iranian Journal of Child Neurology. 15, 3 (Jul. 2021). DOI:https://doi.org/10.22037/ijcn.v15i3.33144.